Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)

MLA

Carol Anne Graham, et al. “Use and Outcomes of Dual Antiplatelet Therapy for Acute Coronary Syndrome in Patients with Chronic Kidney Disease: Insights from the Canadian Observational Antiplatelet Study (COAPT).” Heart and Vessels, vol. 37, Jan. 2022, pp. 1291–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........72ad544e11eb651b12ec6d9867c5490a&authtype=sso&custid=ns315887.

APA

Carol Anne Graham, Mary K. Tan, Derek P. Chew, Christopher P. Gale, Keith A. A. Fox, Akshay Bagai, Mark A. Henderson, Ata ur Rehman Quraishi, Jean-Pierre Déry, Asim N. Cheema, Harold Fisher, David Brieger, Sohrab R. Lutchmedial, Shahar Lavi, Brian Y. L. Wong, Tomas Cieza, Shamir R. Mehta, Neil Brass, Shaun G. Goodman, & Andrew T. Yan. (2022). Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT). Heart and Vessels, 37, 1291–1298.

Chicago

Carol Anne Graham, Mary K. Tan, Derek P. Chew, Christopher P. Gale, Keith A. A. Fox, Akshay Bagai, Mark A. Henderson, et al. 2022. “Use and Outcomes of Dual Antiplatelet Therapy for Acute Coronary Syndrome in Patients with Chronic Kidney Disease: Insights from the Canadian Observational Antiplatelet Study (COAPT).” Heart and Vessels 37 (January): 1291–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........72ad544e11eb651b12ec6d9867c5490a&authtype=sso&custid=ns315887.